Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Sulbactam

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioVersys Starts Pivotal RIV-TARGET Trial of BV100 for HABP/VABP
    BioVersys Starts Pivotal RIV-TARGET Trial of BV100 for HABP/VABP

    16 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/16/3275014/0/en/BioVersys-Announces-First-Patient-First-Visit-in-HABP-VABP-Pivotal-Phase-3-RIV-TARGET-Trial-of-BV100.html

    GLOBENEWSWIRE
    16 Apr 2026
    Share Share
    Innoviva’s ZEVTERA, XACDURO Nominated for 2025 Prix Galien
    Innoviva’s ZEVTERA, XACDURO Nominated for 2025 Prix Galien

    13 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250813478127/en/Innoviva-Specialty-Therapeutics-Antimicrobial-Therapies-ZEVTERA-and-XACDURO-Nominated-for-the-2025-Prix-Galien-USA-Best-Pharmaceutical-Product-Award

    BUSINESSWIRE
    13 Aug 2025
    Share Share
    Zai Lab & Pfizer Announce Collaboration on Antibacterial Drug
    Zai Lab & Pfizer Announce Collaboration on Antibacterial Drug

    21 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241121825806/en

    BUSINESSWIRE
    21 Nov 2024
    Share Share
    Enforcement Report - Week of May 24, 2023
    Enforcement Report - Week of May 24, 2023

    24 May 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-24-2023-89772.pdf

    FDA
    24 May 2023
    Share Share
    Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO
    Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO

    23 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230523005961/en

    BUSINESSWIRE
    23 May 2023
    Share Share
    Pfizer halts 4 antibiotics in India due to production issues
    Pfizer halts 4 antibiotics in India due to production issues

    19 May 2023

    // Joseph Keenan FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/pfizer-puts-kibosh-4-antibiotics-india-due-manufacturing-issues

    Joseph Keenan FIERCE PHARMA
    19 May 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.